CARDIZEM LA (diltiazem hydrochloride) Bausch Patent: 6,923,984 Expiration: Feb 25, 2021 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of February 21, 2021 Read Post »
Annual Drug Patent Expirations for BRIVIACT Briviact is a drug marketed by Ucb Inc and is included in three NDAs.
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included
New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR Read Post »
CLARINEX-D 12 HOUR (desloratadine; pseudoephedrine sulfate) Merck sharp dohme Patent: 6,709,676 Expiration: Feb 18, 2021 See More … For more
Drug Patent Expirations for the Week of February 14, 2021 Read Post »
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There
Annual Drug Patent Expirations for CRIXIVAN Crixivan is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug CRIXIVAN Read Post »
ENJUVIA (estrogens, conjugated synthetic b) Aspen Patent: 6,855,703 Expiration: Feb 12, 2021 See More … For more information on how
Drug Patent Expirations for the Week of February 7, 2021 Read Post »
ENJUVIA (estrogens, conjugated synthetic b) Aspen Patent: 6,855,703 Expiration: Feb 12, 2021 See More … For more information on how
Drug Patent Expirations for the Week of February 7, 2021 Read Post »
Annual Drug Patent Expirations for CRESTOR Crestor is a drug marketed by IPR and is included in one NDA. It
Get fresh news and insights, drug patent expirations & more…
